p.1
p.41
p.77
p.127
p.159
p.173
E-Cadherin – Fc Chimeric Protein-Based Biomaterial: Breaking the Barriers in Stem Cell Technology and Regenerative Medicine
Abstract:
Chimeric proteins have been used for years for various purposes ranging from biomaterials to candidate drug molecules, and from bench to bulk. Regenerative medicine needs various kinds of proteins for providing essential factors for maintaining starting cells, like induced pluripotent stem cells (iPSC), and renewal, proliferation, targeted differentiation of these cells, and as extracellular matrix for the experimental cells. However, there are several challenges associated with making functional chimeric proteins for effective application as biomaterial in this field. Fc-chimeric protein technology could be an effective solution to overcome many of them. These tailored proteins are recently becoming superior choice of biomaterials in stem cell technology and regenerative medicine due to their specific advantageous biophysical and biochemical properties over other chimeric forms of same proteins. Recent advances in recombinant protein-related science and technology also expedited the popularity of this kind of engineered protein. Over the last decade our lab has been pioneering this field, and we and others have been successfully applied Fc-chimeric proteins to overcome many critical issues in stem cell technologies targeting regenerative medicine and tissue engineering. Fc-chimeric protein-based biomaterials, specifically, E-cad-Fc have been preferentially applied for coating of cell culture plates for establishing xenogeneic-agent free monolayer stem cell culture and their maintenance, enhanced directed differentiation of stem cells to specific lineages, and non-enzymatic on-site one-step purification of target cells. Here the technology, recent discoveries, and future direction related with the E-cad-Fc-chimeric protein in connection with regenerative medicine are described.
Info:
Periodical:
Pages:
41-76
Citation:
Online since:
September 2013
Authors:
Price:
Permissions:
[1] M. Nagaoka, H.L. Jiang, T. Hoshiba, T. Akaike, C.S. Cho, Application of recombinant fusion proteins for tissue engineering, Ann. Biomed. Eng. 38 (2010) 683-693.
[2] J.H. Collier, T. Segura, Evolving the use of peptides as components of biomaterials, Biomaterials 32 (2011) 4198-4204.
[3] S.H. Kim, J. Turnbull, S. Guimond, Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor, J. Endocrinol. 209 (2011) 139-151.
DOI: 10.1530/joe-10-0377
[4] R. Assenberg, P.T. Wan, S. Geisse, L.M. Mayr, Advances in recombinant protein expression for use in pharmaceutical research, Curr. Opin. Struct. Biol. 23 (2013) 393-402.
[5] M. Yu, F. Du, H. Ise, W. Zhao, Y. Zhang, Y. Yu, F. Yao, J. Yang, T. Akaike, Preparation and characterization of a VEGF-Fc fusion protein matrix for enhancing HUVEC growth, Biotechnol. Lett. 34 (2012) 1765-1771.
[6] A. Haque, B. Hexig, Q. Meng, S. Hossain, M. Nagaoka, T. Akaike, The effect of recombinant E-cadherin substratum on the differentiation of endoderm-derived hepatocyte-like cells from embryonic stem cells, Biomaterials 32 (2011) 2032-2042.
[7] X.S. Yue, Y. Murakami, T. Tamai, M. Nagaoka, C.S. Cho, Y. Ito, T. Akaike, A fusion protein N-cadherin-Fc as an artificial extracellular matrix surface for maintenance of stem cell features, Biomaterials 31 (2010) 5287-5296.
[8] D.J. Capon, S.M. Chamow, J. Mordenti, S.A. Marsters, T. Gregory, H. Mitsuya, R.A. Byrn, C. Lucas, F.M. Wurm, J.E. Groopman, et al., Designing CD4 immunoadhesins for AIDS therapy, Nature 337 (1989) 525-531.
DOI: 10.1038/337525a0
[9] A.L. Nelson, J.M. Reichert, Development trends for therapeutic antibody fragments, Nat. Biotechnol. 27 (2009) 331-337.
DOI: 10.1038/nbt0409-331
[10] J. Zhang, J. Carter, S. Siu, J.W. O'Neill, A.H. Gates, J. Delaney, C. Mehlin, Fusion partners as a tool for the expression of difficult proteins in mammalian cells, Curr. Pharm. Biotechnol. 11 (2010) 241-245.
[11] A. Beck, J.M. Reichert, Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies, MAbs 3 (2011) 415-416.
[12] D.M. Czajkowsky, J. Hu, Z. Shao, R.J. Pleass, Fc-fusion proteins: new developments and future perspectives, EMBO Mol. Med. 4 (2012) 1015-1028.
[13] M. Nagaoka, Y. Hagiwara, K. Takemura, Y. Murakami, J. Li, S.A. Duncan, T. Akaike, Design of the artificial acellular feeder layer for the efficient propagation of mouse embryonic stem cells, J. Biol. Chem. 283 (2008) 26468-26476.
[14] D.C. Roopenian, S. Akilesh, FcRn: the neonatal Fc receptor comes of age, Nat. Rev. Immunol. 7 (2007) 715-725.
DOI: 10.1038/nri2155
[15] R.E. Kontermann, Strategies for extended serum half-life of protein therapeutics, Curr. Opin. Biotechnol. 22 (2011) 868-876.
[16] F. Nimmerjahn, J.V. Ravetch, Fcgamma receptors as regulators of immune responses, Nat. Rev. Immunol. 8 (2008) 34-47.
DOI: 10.1038/nri2206
[17] M. Nagaoka, T. Akaike, Single amino acid substitution in the mouse IgG1 Fc region induces drastic enhancement of the affinity to protein A, Protein. Eng. 16 (2003) 243-245.
[18] Y. Huang, G.B. Willars, Generation of epitope-tagged GPCRs, Methods Mol. Biol. 746 (2011) 53-84.
[19] A. Bialkowska, X.Y. Zhang, J. Reiser, Improved tagging strategy for protein identification in mammalian cells, BMC Genomics 6 (2005) 113.
[20] J.W. Jarvik, C.A. Telmer, Epitope tagging, Annu. Rev. Genet. 32 (1998) 601-618.
[21] S. Sakai, J. Kim, B. Hexig, Y. Okahata, C.S. Cho, T. Akaike, Adsorption behaviors of recombinant E-cadherin-IgG Fc fusion protein on polystyrene surface, Colloids Surf B Biointerfaces 94 (2012) 192-198.
[22] J. Turkova, Oriented immobilization of biologically active proteins as a tool for revealing protein interactions and function, J. Chromatogr. B Biomed. Sci. Appl. 722 (1999) 11-31.
[23] H. Nagashima, K. Kaneko, A. Yamanoi, S. Motoi, S. Konakahara, J. Kohroki, Y. Masuho, TNF receptor II fusion protein with tandemly repeated Fc domains, J. Biochem. 149 (2011) 337-346.
DOI: 10.1093/jb/mvq149
[24] D.N. Mekhaiel, D.M. Czajkowsky, J.T. Andersen, J. Shi, M. El-Faham, M. Doenhoff, R.S. McIntosh, I. Sandlie, J. He, J. Hu, Z. Shao, R.J. Pleass, Polymeric human Fc-fusion proteins with modified effector functions, Sci. Rep. 1 (2011) 124.
DOI: 10.1038/srep00124
[25] M. Nagaoka, H. Ise, T. Akaike, Immobilized E-cadherin model can enhance cell attachment and differentiation of primary hepatocytes but not proliferation, Biotechnol. Lett. 24 (2002) 1857-1862.
[26] K. Ogiwara, M. Nagaoka, C.S. Cho, T. Akaike, Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc, Biotechnol. Lett. 27 (2005) 1633-1637.
[27] K. Azuma, M. Nagaoka, C.S. Cho, T. Akaike, An artificial extracellular matrix created by hepatocyte growth factor fused to IgG-Fc, Biomaterials 31 (2010) 802-809.
[28] H. Oda, M. Takeichi, Evolution: structural and functional diversity of cadherin at the adherens junction, J. Cell. Biol. 193 (2011) 1137-1146.
[29] C.M. Niessen, D. Leckband, A.S. Yap, Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation, Physiol. Rev. 91 (2011) 691-731.
[30] D. Vestweber, R. Kemler, Rabbit antiserum against a purified surface glycoprotein decompacts mouse preimplantation embryos and reacts with specific adult tissues, Exp. Cell. Res. 152 (1984) 169-178.
[31] Y. Shirayoshi, T.S. Okada, M. Takeichi, The calcium-dependent cell-cell adhesion system regulates inner cell mass formation and cell surface polarization in early mouse development, Cell 35 (1983) 631-638.
[32] F. Hyafil, C. Babinet, F. Jacob, Cell-cell interactions in early embryogenesis: a molecular approach to the role of calcium, Cell 26 (1981) 447-454.
[33] M. Takeichi, Functional correlation between cell adhesive properties and some cell surface proteins, J. Cell. Biol. 75 (1977) 464-474.
DOI: 10.1083/jcb.75.2.464
[34] M. Horie, A. Ito, T. Kiyohara, Y. Kawabe, M. Kamihira, E-cadherin gene-engineered feeder systems for supporting undifferentiated growth of mouse embryonic stem cells, J. Biosci. Bioeng. 110 (2010) 582-587.
[35] T. Chen, D. Yuan, B. Wei, J. Jiang, J. Kang, K. Ling, Y. Gu, J. Li, L. Xiao, G. Pei, E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation, Stem Cells 28 (2010) 1315-1325.
DOI: 10.1002/stem.456
[36] L. Larue, C. Antos, S. Butz, O. Huber, V. Delmas, M. Dominis, R. Kemler, A role for cadherins in tissue formation, Development 122 (1996) 3185-3194.
[37] D. Riethmacher, V. Brinkmann, C. Birchmeier, A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development, Proc. Natl. Acad. Sci. USA 92 (1995) 855-859.
[38] L. Larue, M. Ohsugi, J. Hirchenhain, R. Kemler, E-cadherin null mutant embryos fail to form a trophectoderm epithelium, Proc. Natl. Acad. Sci. USA 91 (1994) 8263-8267.
[39] L. Li, S.A. Bennett, L. Wang, Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells, Cell Adh. Migr. 6 (2012) 59-70.
DOI: 10.4161/cam.19583
[40] F. Balzac, M. Avolio, S. Degani, I. Kaverina, M. Torti, L. Silengo, J.V. Small, S.F. Retta, E-cadherin endocytosis regulates the activity of Rap1: a traffic light GTPase at the crossroads between cadherin and integrin function, J. Cell Sci. 118 (2005) 4765-4783.
DOI: 10.1242/jcs.02584
[41] K. Xiao, D.F. Allison, K.M. Buckley, M.D. Kottke, P.A. Vincent, V. Faundez, A.P. Kowalczyk, Cellular levels of p.120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells, J. Cell Biol. 163 (2003) 535-545.
[42] R.C. Ireton, M.A. Davis, J. van Hengel, D.J. Mariner, K. Barnes, M.A. Thoreson, P.Z. Anastasiadis, L. Matrisian, L.M. Bundy, L. Sealy, B. Gilbert, F. van Roy, A.B. Reynolds, A novel role for p.120 catenin in E-cadherin function, J. Cell Biol. 159 (2002) 465-476.
[43] M.A. Thoreson, P.Z. Anastasiadis, J.M. Daniel, R.C. Ireton, M.J. Wheelock, K.R. Johnson, D.K. Hummingbird, A.B. Reynolds, Selective uncoupling of p.120(ctn) from E-cadherin disrupts strong adhesion, J. Cell Biol. 148 (2000) 189-202.
[44] M. Cavey, M. Rauzi, P.F. Lenne, T. Lecuit, A two-tiered mechanism for stabilization and immobilization of E-cadherin, Nature 453 (2008) 751-756.
DOI: 10.1038/nature06953
[45] S. Yamada, S. Pokutta, F. Drees, W.I. Weis, W.J. Nelson, Deconstructing the cadherin-catenin-actin complex, Cell 123 (2005) 889-901.
[46] F. Palacios, J.S. Tushir, Y. Fujita, C. D'Souza-Schorey, Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions, Mol. Cell Biol. 25 (2005) 389-402.
[47] A. Kobielak, H.A. Pasolli, E. Fuchs, Mammalian formin-1 participates in adherens junctions and polymerization of linear actin cables, Nat. Cell Biol. 6 (2004) 21-30.
DOI: 10.1038/ncb1075
[48] J. Xu, C. Zhu, Y. Zhang, N. Jiang, S. Li, Z. Su, T. Akaike, J. Yang, hE-cadherin-Fc fusion protein coated surface enhances the adhesion and proliferation of human mesenchymal stem cells, Colloids Surf B Biointerfaces 109 (2013) 97-102.
[49] T. Redmer, S. Diecke, T. Grigoryan, A. Quiroga-Negreira, W. Birchmeier, D. Besser, E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming, EMBO Rep 12 (2011) 720-726.
[50] R. Awata, H. Sawai, K. Imai, K. Terada, H. Senoo, T. Sugiyama, Morphological comparison and functional reconstitution of rat hepatic parenchymal cells on various matrices, J. Gastroenterol Hepatol. 13 Suppl (1998) S55-61.
[51] X. Zhang, W. Wharton, M. Donovan, D. Coppola, R. Croxton, W.D. Cress, W.J. Pledger, Density-dependent growth inhibition of fibroblasts ectopically expressing p.27(kip1), Mol. Biol. Cell 11 (2000) 2117-2130.
[52] N. Kojima, T. Kinoshita, A. Kamiya, K. Nakamura, K. Nakashima, T. Taga, A. Miyajima, Cell density-dependent regulation of hepatic development by a gp130-independent pathway, Biochem. Biophys. Res. Commun. 277 (2000) 152-158.
[53] A. Haque, X.S. Yue, A. Motazedian, Y. Tagawa, T. Akaike, Characterization and neural differentiation of mouse embryonic and induced pluripotent stem cells on cadherin-based substrata, Biomaterials 33 (2012) 5094-5106.
[54] M. Nagaoka, K. Si-Tayeb, T. Akaike, S.A. Duncan, Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum, BMC Dev. Biol. 10 (2010) 60.
[55] M. Nagaoka, U. Koshimizu, S. Yuasa, F. Hattori, H. Chen, T. Tanaka, M. Okabe, K. Fukuda, T. Akaike, E-cadherin-coated plates maintain pluripotent ES cells without colony formation, PLoS One 1 (2006) e15.
[56] C. Xu, J. Jiang, V. Sottile, J. McWhir, J. Lebkowski, M.K. Carpenter, Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth, Stem Cells 22 (2004) 972-980.
[57] C.V. Alvarez, M. Garcia-Lavandeira, M.E. Garcia-Rendueles, E. Diaz-Rodriguez, A.R. Garcia-Rendueles, S. Perez-Romero, T.V. Vila, J.S. Rodrigues, P.V. Lear, S.B. Bravo, Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells, J. Mol. Endocrinol. 49 (2012) R89-111.
DOI: 10.1530/jme-12-0072
[58] A. Dar, H. Domev, O. Ben-Yosef, M. Tzukerman, N. Zeevi-Levin, A. Novak, I. Germanguz, M. Amit, J. Itskovitz-Eldor, Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb, Circulation 125 (2012) 87-99.
[59] E. Szabo, S. Rampalli, R.M. Risueno, A. Schnerch, R. Mitchell, A. Fiebig-Comyn, M. Levadoux-Martin, M. Bhatia, Direct conversion of human fibroblasts to multilineage blood progenitors, Nature 468 (2010) 521-526.
DOI: 10.1038/nature09591
[60] G. Lee, S.M. Chambers, M.J. Tomishima, L. Studer, Derivation of neural crest cells from human pluripotent stem cells, Nat Protoc. 5 (2010) 688-701.
[61] A.E. Grigoriadis, M. Kennedy, A. Bozec, F. Brunton, G. Stenbeck, I.H. Park, E.F. Wagner, G.M. Keller, Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells, Blood 115 (2010) 2769-2776.
[62] S. Yao, S. Chen, J. Clark, E. Hao, G.M. Beattie, A. Hayek, S. Ding, Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions, Proc. Natl. Acad. Sci. USA 103 (2006) 6907-6912.
[63] K.A. D'Amour, A.D. Agulnick, S. Eliazer, O.G. Kelly, E. Kroon, E.E. Baetge, Efficient differentiation of human embryonic stem cells to definitive endoderm, Nat. Biotechnol. 23 (2005) 1534-1541.
DOI: 10.1038/nbt1163
[64] K. Takahashi, S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell 126 (2006) 663-676.
[65] J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, J.M. Jones, Embryonic stem cell lines derived from human blastocysts, Science 282 (1998) 1145-1147.
[66] T.E. Ludwig, V. Bergendahl, M.E. Levenstein, J. Yu, M.D. Probasco, J.A. Thomson, Feeder-independent culture of human embryonic stem cells, Nat. Methods 3 (2006) 637-646.
DOI: 10.1038/nmeth902
[67] M.E. Levenstein, T.E. Ludwig, R.H. Xu, R.A. Llanas, K. VanDenHeuvel-Kramer, D. Manning, J.A. Thomson, Basic fibroblast growth factor support of human embryonic stem cell self-renewal, Stem Cells 24 (2006) 568-574.
[68] L. Wang, L. Li, P. Menendez, C. Cerdan, M. Bhatia, Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development, Blood 105 (2005) 4598-4603.
[69] M.H. Stewart, S.C. Bendall, M. Bhatia, Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency, J. Mol. Med. (Berl) 86 (2008) 875-886.
[70] C. Xu, M.S. Inokuma, J. Denham, K. Golds, P. Kundu, J.D. Gold, M.K. Carpenter, Feeder-free growth of undifferentiated human embryonic stem cells, Nat. Biotechnol. 19 (2001) 971-974.
DOI: 10.1038/nbt1001-971
[71] S. Vukicevic, H.K. Kleinman, F.P. Luyten, A.B. Roberts, N.S. Roche, A.H. Reddi, Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components, Exp. Cell. Res. 202 (1992) 1-8.
[72] H.K. Kleinman, M.L. McGarvey, L.A. Liotta, P.G. Robey, K. Tryggvason, G.R. Martin, Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma, Biochemistry 21 (1982) 6188-6193.
DOI: 10.1021/bi00267a025
[73] H.K. Kleinman, M.L. McGarvey, J.R. Hassell, V.L. Star, F.B. Cannon, G.W. Laurie, G.R. Martin, Basement membrane complexes with biological activity, Biochemistry 25 (1986) 312-318.
DOI: 10.1021/bi00350a005
[74] H.K. Kleinman, G.R. Martin, Matrigel: basement membrane matrix with biological activity, Semin. Cancer Biol. 15 (2005) 378-386.
[75] J. Carlson, R. Garg, S.R. Compton, C. Zeiss, E. Uchio, Poliomyelitis in SCID Mice Following Injection of Basement Membrane Matrix Contaminated with Lactate Dehydrogenase-elevating Virus, J. Am. Assoc. Lab. Anim. Sci. 47 (2008) 80-81.
[76] T. Miyazaki, S. Futaki, K. Hasegawa, M. Kawasaki, N. Sanzen, M. Hayashi, E. Kawase, K. Sekiguchi, N. Nakatsuji, H. Suemori, Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells, Biochem. Biophys. Res. Commun. 375 (2008) 27-32.
[77] H. Ido, S. Ito, Y. Taniguchi, M. Hayashi, R. Sato-Nishiuchi, N. Sanzen, Y. Hayashi, S. Futaki, K. Sekiguchi, Laminin isoforms containing the gamma3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C-terminal regions of the gamma1 and gamma2 chains, J. Biol. Chem. 283 (2008) 28149-28157.
[78] A. Domogatskaya, S. Rodin, A. Boutaud, K. Tryggvason, Laminin-511 but not -332, -111, or -411 enables mouse embryonic stem cell self-renewal in vitro, Stem Cells 26 (2008) 2800-2809.
[79] Y. Hayashi, M.K. Furue, T. Okamoto, K. Ohnuma, Y. Myoishi, Y. Fukuhara, T. Abe, J.D. Sato, R. Hata, M. Asashima, Integrins regulate mouse embryonic stem cell self-renewal, Stem Cells 25 (2007) 3005-3015.
[80] T.E. Ludwig, M.E. Levenstein, J.M. Jones, W.T. Berggren, E.R. Mitchen, J.L. Frane, L.J. Crandall, C.A. Daigh, K.R. Conard, M.S. Piekarczyk, R.A. Llanas, J.A. Thomson, Derivation of human embryonic stem cells in defined conditions, Nat. Biotechnol. 24 (2006) 185-187.
DOI: 10.1038/nbt1177
[81] D.P. Gearing, N.M. Gough, J.A. King, D.J. Hilton, N.A. Nicola, R.J. Simpson, E.C. Nice, A. Kelso, D. Metcalf, Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF), EMBO J 6 (1987) 3995-4002.
[82] H. Baumann, G.G. Wong, Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor, J. Immunol. 143 (1989) 1163-1167.
[83] N. Ferrara, J. Winer, W.J. Henzel, Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor, Proc. Natl. Acad. Sci. USA 89 (1992) 698-702.
[84] M. Nagaoka, H. Ise, I. Harada, U. Koshimizu, A. Maruyama, T. Akaike, Embryonic undifferentiated cells show scattering activity on a surface coated with immobilized E-cadherin, J. Cell Biochem. 103 (2008) 296-310.
DOI: 10.1002/jcb.21406
[85] N. Harb, T.K. Archer, N. Sato, The Rho-Rock-Myosin signaling axis determines cell-cell integrity of self-renewing pluripotent stem cells, PLoS One 3 (2008) e3001.
[86] K.F. Kelly, D.Y. Ng, G. Jayakumaran, G.A. Wood, H. Koide, B.W. Doble, beta-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism, Cell Stem Cell 8 (2011) 214-227.
[87] R.N. Moore, J.F. Cherry, V. Mathur, R. Cohen, M. Grumet, P.V. Moghe, E-cadherin-expressing feeder cells promote neural lineage restriction of human embryonic stem cells, Stem Cells Dev. 21 (2012) 30-41.
[88] Z. Zhang, Y. Gao, A. Gordon, Z.Z. Wang, Z. Qian, W.S. Wu, Efficient generation of fully reprogrammed human iPS cells via polycistronic retroviral vector and a new cocktail of chemical compounds, PLoS One 6 (2011) e26592.
[89] B. Liao, X. Bao, L. Liu, S. Feng, A. Zovoilis, W. Liu, Y. Xue, J. Cai, X. Guo, B. Qin, R. Zhang, J. Wu, L. Lai, M. Teng, L. Niu, B. Zhang, M.A. Esteban, D. Pei, MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition, J. Biol. Chem. 286 (2011) 17359-17364.
[90] H. Kim, G. Lee, Y. Ganat, E.P. Papapetrou, I. Lipchina, N.D. Socci, M. Sadelain, L. Studer, miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells, Cell Stem Cell 8 (2011) 695-706.
[91] N. Xu, T. Papagiannakopoulos, G. Pan, J.A. Thomson, K.S. Kosik, MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells, Cell 137 (2009) 647-658.
[92] I.H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, T.A. Ince, P.H. Lerou, M.W. Lensch, G.Q. Daley, Reprogramming of human somatic cells to pluripotency with defined factors, Nature 451 (2008) 141-146.
DOI: 10.1038/nature06534
[93] T. Aasen, A. Raya, M.J. Barrero, E. Garreta, A. Consiglio, F. Gonzalez, R. Vassena, J. Bilic, V. Pekarik, G. Tiscornia, M. Edel, S. Boue, J.C. Izpisua Belmonte, Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes, Nat. Biotechnol. 26 (2008) 1276-1284.
DOI: 10.1038/nbt.1503
[94] J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, R. Stewart, Slukvin, II, J.A. Thomson, Induced pluripotent stem cell lines derived from human somatic cells, Science 318 (2007) 1917-1920.
[95] K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, S. Yamanaka, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell 131 (2007) 861-872.
[96] R. Li, J. Liang, S. Ni, T. Zhou, X. Qing, H. Li, W. He, J. Chen, F. Li, Q. Zhuang, B. Qin, J. Xu, W. Li, J. Yang, Y. Gan, D. Qin, S. Feng, H. Song, D. Yang, B. Zhang, L. Zeng, L. Lai, M.A. Esteban, D. Pei, A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts, Cell Stem Cell 7 (2010) 51-63.
[97] A.M. Eastham, H. Spencer, F. Soncin, S. Ritson, C.L. Merry, P.L. Stern, C.M. Ward, Epithelial-mesenchymal transition events during human embryonic stem cell differentiation, Cancer Res. 67 (2007) 11254-11262.
[98] C. Hogan, N. Serpente, P. Cogram, C.R. Hosking, C.U. Bialucha, S.M. Feller, V.M. Braga, W. Birchmeier, Y. Fujita, Rap1 regulates the formation of E-cadherin-based cell-cell contacts, Mol. Cell Biol. 24 (2004) 6690-6700.
[99] Y.H. Loh, Q. Wu, J.L. Chew, V.B. Vega, W. Zhang, X. Chen, G. Bourque, J. George, B. Leong, J. Liu, K.Y. Wong, K.W. Sung, C.W. Lee, X.D. Zhao, K.P. Chiu, L. Lipovich, V.A. Kuznetsov, P. Robson, L.W. Stanton, C.L. Wei, Y. Ruan, B. Lim, H.H. Ng, The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells, Nat. Genet. 38 (2006) 431-440.
DOI: 10.1038/ng1760
[100] A. Singh, S. Suri, T. Lee, J.M. Chilton, M.T. Cooke, W. Chen, J. Fu, S.L. Stice, H. Lu, T.C. McDevitt, A.J. Garcia, Adhesion strength-based, label-free isolation of human pluripotent stem cells, Nat. Methods 10 (2013) 438-444.
DOI: 10.1038/nmeth.2437
[101] L.G. Villa-Diaz, A.M. Ross, J. Lahann, P.H. Krebsbach, Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings, Stem Cells 31 (2013) 1-7.
DOI: 10.1002/stem.1260
[102] M. Sundberg, L. Jansson, J. Ketolainen, H. Pihlajamaki, R. Suuronen, H. Skottman, J. Inzunza, O. Hovatta, S. Narkilahti, CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells, Stem Cell Res. 2 (2009) 113-124.
[103] J. Pruszak, K.C. Sonntag, M.H. Aung, R. Sanchez-Pernaute, O. Isacson, Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations, Stem Cells 25 (2007) 2257-2268.